104 related articles for article (PubMed ID: 10814101)
1. A practical and efficient preparation of the releasable naphthosultam side chain of a novel anti-MRSA carbapenem.
Miller RA; Humphrey GR; Lieberman DR; Ceglia SS; Kennedy DJ; Grabowski EJ; Reider PJ
J Org Chem; 2000 Mar; 65(5):1399-406. PubMed ID: 10814101
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.
Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M
Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of an anti-methicillin-resistant Staphylococcus aureus (MRSA) carbapenem via stannatrane-mediated Stille coupling.
Jensen MS; Yang C; Hsiao Y; Rivera N; Wells KM; Chung JY; Yasuda N; Hughes DL; Reider PJ
Org Lett; 2000 Apr; 2(8):1081-4. PubMed ID: 10804559
[TBL] [Abstract][Full Text] [Related]
4. Reduced immunotoxicity and preservation of antibacterial activity in a releasable side-chain carbapenem antibiotic.
Rosen H; Hajdu R; Silver L; Kropp H; Dorso K; Kohler J; Sundelof JG; Huber J; Hammond GG; Jackson JJ; Gill CJ; Thompson R; Pelak BA; Epstein-Toney JH; Lankas G; Wilkening RR; Wildonger KJ; Blizzard TA; DiNinno FP; Ratcliffe RW; Heck JV; Kozarich JW; Hammond ML
Science; 1999 Jan; 283(5402):703-6. PubMed ID: 9924033
[TBL] [Abstract][Full Text] [Related]
5. Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists.
Malleron JL; Comte MT; Gueremy C; Peyronel JF; Truchon A; Blanchard JC; Doble A; Piot O; Zundel JL; Huon C
J Med Chem; 1991 Aug; 34(8):2477-83. PubMed ID: 1908521
[TBL] [Abstract][Full Text] [Related]
6. 2-Naphthylcarbapenems: broad spectrum antibiotics with enhanced potency against MRSA.
Greenlee ML; DiNinno F; Herrmann JJ; Jaworsky C; Muthard DA; Salzmann TN
Bioorg Med Chem Lett; 1999 Oct; 9(19):2893-6. PubMed ID: 10522713
[TBL] [Abstract][Full Text] [Related]
7. Dicationic dithiocarbamate carbapenems with anti-MRSA activity.
Imamura H; Ohtake N; Jona H; Shimizu A; Moriya M; Sato H; Sugimoto Y; Ikeura C; Kiyonaga H; Nakano M; Nagano R; Abe S; Yamada K; Hashizume T; Morishima H
Bioorg Med Chem; 2001 Jun; 9(6):1571-8. PubMed ID: 11408176
[TBL] [Abstract][Full Text] [Related]
8. The synthesis and anti-MRSA activity of amidinium-substituted 2-dibenzofuranylcarbapenems.
Laub JB; Greenlee ML; DiNinno F; Huber JL; Sundelof JG
Bioorg Med Chem Lett; 1999 Oct; 9(20):2973-6. PubMed ID: 10571158
[TBL] [Abstract][Full Text] [Related]
9. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Matsuhisa E; Takata H; Takata T; Atsumi K; Iwamatsu K; Shitara E
Bioorg Med Chem; 2007 Oct; 15(19):6379-87. PubMed ID: 17681767
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of J-111,347, a novel 1 beta-methylcarbapenem with broad-spectrum antibacterial activity.
Imamura H; Ohtake N; Sakuraba S; Shimizu A; Yamada K; Morishima H
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):310-1. PubMed ID: 10705531
[TBL] [Abstract][Full Text] [Related]
11. Total syntheses of the antibacterial natural product abyssomicin C.
Peters R; Fischer DF
Angew Chem Int Ed Engl; 2006 Sep; 45(35):5736-9. PubMed ID: 16906621
[No Abstract] [Full Text] [Related]
12. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and molecular modelling of new bulky Fananserin derivatives with altered pharmacological profile as potential antidepressants.
Zaręba P; Jaśkowska J; Czekaj I; Satała G
Bioorg Med Chem; 2019 Aug; 27(15):3396-3407. PubMed ID: 31253535
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392.
Ratcliffe RW; Wilkening RR; Wildonger KJ; Waddell ST; Santorelli GM; Parker DL; Morgan JD; Blizzard TA; Hammond ML; Heck JV; Huber J; Kohler J; Dorso KL; St Rose E; Sundelof JG; May WJ; Hammond GG
Bioorg Med Chem Lett; 1999 Mar; 9(5):679-84. PubMed ID: 10201828
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.
López-Rodríguez ML; Porras E; Morcillo MJ; Benhamú B; Soto LJ; Lavandera JL; Ramos JA; Olivella M; Campillo M; Pardo L
J Med Chem; 2003 Dec; 46(26):5638-50. PubMed ID: 14667218
[TBL] [Abstract][Full Text] [Related]
17. A practical preparation of the key intermediate for penems and carbapenems synthesis.
Grzeszczyk B; Stecko S; Mucha Ł; Staszewska-Krajewska O; Chmielewski M; Furman B
J Antibiot (Tokyo); 2013 Mar; 66(3):161-3. PubMed ID: 23532020
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue.
Balan D; Burns CJ; Fisk NG; Hügel H; Huang DC; Segal D; White C; Wagler J; Rizzacasa MA
Org Biomol Chem; 2012 Oct; 10(40):8147-53. PubMed ID: 22964776
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of fused bicyclic inhibitors targeting the L5 loop site of centromere-associated protein E.
Hirayama T; Okaniwa M; Banno H; Kakei H; Ohashi A; Ohori M; Nambu T; Iwai K; Kawamoto T; Yokota A; Miyamoto M; Ishikawa T
Bioorg Med Chem Lett; 2016 Sep; 26(17):4296-300. PubMed ID: 27476141
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric syntheses of fused bicyclic lactams.
Lim SH; Ma S; Beak P
J Org Chem; 2001 Dec; 66(26):9056-62. PubMed ID: 11749647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
